Skip to main content
Premium Trial:

Request an Annual Quote

Tina Nova and Craig Johnson

GenomeDx Biosciences has appointed Tina Nova and Craig Johnson to its board of directors. Nova co-founded the molecular diagnostics company Genoptix in 2000 and served as president, CEO, and director until its acquisition by Novartis in 2011. Prior to that, Nova co-founded Nanogen, where she served as president and chief operations officer. Johnson is currently director for Mirati Therapeutics, La Jolla Pharmaceutical Company, and Theron Therapeutics. He has also served as chief financial officer at NovaDel Pharma, TorreyPines Therapeutics, and MitoKor. 

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.